130 related articles for article (PubMed ID: 16271921)
1. Acarbose attenuates the hypotensive response to sucrose and slows gastric emptying in the elderly.
Gentilcore D; Bryant B; Wishart JM; Morris HA; Horowitz M; Jones KL
Am J Med; 2005 Nov; 118(11):1289. PubMed ID: 16271921
[No Abstract] [Full Text] [Related]
2. Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect.
Ranganath L; Norris F; Morgan L; Wright J; Marks V
Diabet Med; 1998 Feb; 15(2):120-4. PubMed ID: 9507911
[TBL] [Abstract][Full Text] [Related]
3. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
[TBL] [Abstract][Full Text] [Related]
4. Acarbose and postprandial hypotension.
Gentilcore D; Horowitz M; Jones KL
Hypertension; 2007 Nov; 50(5):e159; author reply e160. PubMed ID: 17846347
[No Abstract] [Full Text] [Related]
5. Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes.
Juntti-Berggren L; Pigon J; Hellström P; Holst JJ; Efendic S
Diabetes Nutr Metab; 2000 Feb; 13(1):7-12. PubMed ID: 10824717
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of glucose and xylose on blood pressure, gastric emptying and incretin hormones in healthy older subjects.
Vanis L; Hausken T; Gentilcore D; Rigda RS; Rayner CK; Feinle-Bisset C; Horowitz M; Jones KL
Br J Nutr; 2011 Jun; 105(11):1644-51. PubMed ID: 21294929
[TBL] [Abstract][Full Text] [Related]
7. Potential for Gut Peptide-Based Therapy in Postprandial Hypotension.
Borg MJ; Xie C; Rayner CK; Horowitz M; Jones KL; Wu T
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444986
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycemia in adolescents with cystic fibrosis: a randomized crossover trial.
Perano SJ; Couper JJ; Horowitz M; Martin AJ; Kritas S; Sullivan T; Rayner CK
J Clin Endocrinol Metab; 2014 Jul; 99(7):2486-93. PubMed ID: 24670086
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.
Enç FY; Imeryüz N; Akin L; Turoğlu T; Dede F; Haklar G; Tekeşin N; Bekiroğlu N; Yeğen BC; Rehfeld JF; Holst JJ; Ulusoy NB
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G752-63. PubMed ID: 11518688
[TBL] [Abstract][Full Text] [Related]
10. The alpha (α)-glucosidase inhibitor, acarbose, attenuates the blood pressure and splanchnic blood flow responses to intraduodenal sucrose in older adults.
Gentilcore D; Vanis L; Wishart JM; Rayner CK; Horowitz M; Jones KL
J Gerontol A Biol Sci Med Sci; 2011 Aug; 66(8):917-24. PubMed ID: 21628676
[TBL] [Abstract][Full Text] [Related]
11. The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes.
Dalsgaard NB; Gasbjerg LS; Hansen LS; Hansen NL; Stensen S; Hartmann B; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
Eur J Endocrinol; 2021 Mar; 184(3):383-394. PubMed ID: 33449919
[TBL] [Abstract][Full Text] [Related]
12. Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetes.
Trahair LG; Horowitz M; Stevens JE; Feinle-Bisset C; Standfield S; Piscitelli D; Rayner CK; Deane AM; Jones KL
Diabetologia; 2015 Aug; 58(8):1769-78. PubMed ID: 26048234
[TBL] [Abstract][Full Text] [Related]
13. [Reducing postprandial glucose levels. Glucosidase antagonists].
Neye H
Pharm Unserer Zeit; 2002; 31(3):272-8. PubMed ID: 12071124
[No Abstract] [Full Text] [Related]
14. Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
Hira T; Koga T; Sasaki K; Hara H
Biochem Biophys Res Commun; 2017 Oct; 492(2):161-165. PubMed ID: 28803984
[TBL] [Abstract][Full Text] [Related]
15. Role of intestinal peptides and the autonomic nervous system in postprandial hypotension in patients with multiple system atrophy.
Fukushima T; Asahina M; Fujinuma Y; Yamanaka Y; Katagiri A; Mori M; Kuwabara S
J Neurol; 2013 Feb; 260(2):475-83. PubMed ID: 22983428
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of acarbose in treating elderly patients with diabetes with postprandial hypotension.
Zhang J; Guo L
J Investig Med; 2017 Apr; 65(4):772-783. PubMed ID: 28213385
[TBL] [Abstract][Full Text] [Related]
17. Does postprandial blood glucose matter and why?
Ceriello A
Endocrinol Nutr; 2009 Dec; 56 Suppl 4():8-11. PubMed ID: 20629222
[No Abstract] [Full Text] [Related]
18. Chlorogenic acid differentially affects postprandial glucose and glucose-dependent insulinotropic polypeptide response in rats.
Tunnicliffe JM; Eller LK; Reimer RA; Hittel DS; Shearer J
Appl Physiol Nutr Metab; 2011 Oct; 36(5):650-9. PubMed ID: 21977912
[TBL] [Abstract][Full Text] [Related]
19. Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis.
Edholm T; Degerblad M; Grybäck P; Hilsted L; Holst JJ; Jacobsson H; Efendic S; Schmidt PT; Hellström PM
Neurogastroenterol Motil; 2010 Nov; 22(11):1191-200, e315. PubMed ID: 20584260
[TBL] [Abstract][Full Text] [Related]
20. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients.
Seifarth C; Bergmann J; Holst JJ; Ritzel R; Schmiegel W; Nauck MA
Diabet Med; 1998 Jun; 15(6):485-91. PubMed ID: 9632123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
